Skip to main content
. Author manuscript; available in PMC: 2014 May 5.
Published in final edited form as: J Clin Oncol. 2008 Mar 1;26(7):1148–1159. doi: 10.1200/JCO.2007.12.4487

Fig. 4.

Fig. 4

Prostate-specific antigen (PSA) progression. An increase of 25% and absolute increase of 2 ng/mL or more above the nadir. Values A, B, and C show rising PSA values that do not meet the criteria. Value D is the first PSA value that is greater than 25% and more than 2 ng/mL above the nadir, confirmed with a further rise in PSA shown by value E. For reporting purposes, PSA progression would be recorded on the date value D was obtained.